rolipram and naloxone
rolipram has been researched along with naloxone in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Assi, AA; Gomaa, A; Hamdy, MM; Mamiya, T; Nabeshima, T; Noda, Y; Sayed, M; Yamada, K | 1 |
Furukawa, S; Hamdy, M; Kameyama, T; Mamiya, T; Nabeshima, T; Noda, Y; Ren, X; Yamada, K | 1 |
Abe, K; Inoue, O; Itoh, T; Kimura, M; Tokumura, M | 1 |
Other Studies
3 other study(ies) available for rolipram and naloxone
Article | Year |
---|---|
A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Morphine Dependence; Naloxone; Narcotic Antagonists; Phosphodiesterase Inhibitors; Proto-Oncogene Proteins c-fos; Rolipram; Substance Withdrawal Syndrome | 2001 |
Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cerebral Cortex; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Male; Mice; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Pain Measurement; Phosphodiesterase Inhibitors; Rolipram; Substance Withdrawal Syndrome; Thalamus | 2001 |
Lack of cyclic AMP-specific phosphodiesterase 4 activation during naloxone-precipitated morphine withdrawal in rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Brain; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Enzyme Activation; Male; Morphine; Naloxone; Rats; Rats, Sprague-Dawley; Rolipram; Substance Withdrawal Syndrome | 2006 |